Estee Lauder among multinationals hit by China lockdowns
Estee Lauder shares fell 9% in early trading.
The devastating effects of COVID-19 lockdowns in China overshadowed a strong quarter at Estee Lauder and shares of the cosmetics company tumbled before the opening bell Wednesday.
International companies that rely on sales in China have been hammered by Beijing's "Zero COVID" policies that have mandated strict periods of isolation for millions of people.
On Wednesday, Estee Lauder lowered its annual adjusted per-share profit expectations from between $7.39 and $7.54, to between $5.25 and $5.40. That's far below Wall Street projections for per-share profits of $7.35 per share, according to a FactSet survey.
SHANGHAI DISNEYLAND VISITORS REPORTEDLY LOCKED IN PARK FOR HOURS OVER A SINGLE COVID CASE
Shares fell 9% in early trading.
An Estee Lauder cosmetics counter is seen in Los Angeles, Aug. 19, 2019. (Reuters/Lucy Nicholson / Reuters)
Bigger companies have not been spared from the effects of China's strict virus policies.
WORKERS WALK OUT OF IPHONE FACTORY, HIGHLIGHTING VIRUS WOES
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| EL | THE ESTÉE LAUDER COMPANIES INC. | 132.91 | -2.04 | -1.51% |
Access to an industrial zone in the central Chinese city of Zhengzhou was suspended Wednesday after the city reported 64 coronavirus cases and workers who assemble Apple iPhones left their factory in the zone following outbreaks.
Workers wait for customers at an Apple retail store in Beijing, China on Wednesday, Feb. 19, 2020. (AP Photo/Ng Han Guan / AP Images)
Starbucks reports earnings Thursday. In its last quarterly financial report, the company said same store sales in China plunged 44%.
COVID-19 OUTBREAK AT FOXCONN'S LARGEST FACTORY IN CHINA SENDS WORKERS FLEEING: REPORTS
Aside from China’s COVID-19 restrictions, Estee Lauder said Wednesday that travel curbs and tightening inventory in Asia and the U.S. will likely weigh on the company during the first half of the year.
As China begins to lock down again due to COVID, the country has approved Livzon Pharmaceutical's COVID-19 vaccine as a booster. (REUTERS/David Kirton/Files / Reuters Photos)
The New York City company earned $489 million, or $1.35 per share, in its fiscal first quarter. Removing restructuring costs, earnings were $1.37 per share, edging out Wall Street projections by 2 cents, according to analysts polled by Zacks Investment Research.
CLICK HERE TO GET THE FOX BUSINESS APP
Estee Lauder Cos. foresees second-quarter earnings in a range of $1.19 to $1.29 per share. Analysts surveyed by Zacks had been projecting $2.84 per share.